Company Filing History:
Years Active: 2017
Title: The Innovative Journey of René Ignacio Rodriguez Curiel
Introduction
René Ignacio Rodriguez Curiel is a notable inventor based in Alcantarilla, Spain. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative processes. His work has led to the development of a unique method for preparing levomilnacipran, a medication used in the treatment of major depressive disorder.
Latest Patents
René holds 1 patent for his invention titled "Process for preparing levomilnacipran." This patent details a new process for preparing levomilnacipran, focusing on the resolution of racemic tw-milnacipran using a derivative of optically active phenylglycine. This innovative approach enhances the efficiency and effectiveness of the drug preparation process.
Career Highlights
René is currently associated with Olon S.p.a., a company known for its commitment to pharmaceutical development and manufacturing. His role at Olon has allowed him to apply his expertise in the field, contributing to advancements in drug formulation and production.
Collaborations
Throughout his career, René has collaborated with esteemed colleagues such as Paolo Maria Farina and Stefano Maiorana. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
René Ignacio Rodriguez Curiel's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in drug development. His patent for the preparation of levomilnacipran showcases his dedication to improving therapeutic options for patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.